SynBac
Traditional process scale up using baculovirus is notoriously problematic, with yields dropping progressively during scale up. SynBac™ are minimized baculoviral genomes created using modern synthetic biology techniques. The SynBac™ project aims to transform fermenter-scale baculoviral production of drug targets, and manufacturing scale production of biopharmaceuticals by creating minimal baculoviral genomes displaying exceptional DNA stability. In addition to improved DNA stability, our minimized genomes form the starting point for applications that require large DNA cargo delivery to mammalian cells, primary cells, or organs.
17th Oct 2020
Recent Posts
-
DNase/RNase-Free Laboratory Consumables for Sample Preparation and Liquid Handling
DNase/RNase-Free Laboratory Consumables for Sample Preparation, Liquid Handling and Storage Laborato …16th Jul 2026 -
cd33 ligand
CD33 Gene - CD33 Molecule Protein Coding Chromosome 19 Immune Receptor Gene ID: 945 Kn …13th Jul 2026 -
Cell Culture Media and Supplements: Key Selection Criteria
Gentaur Expert Guide Cell Culture Media and Supplements: Key Selection Criteria A practical guide …5th May 2026